Mobile App-Delivered ACT Shows Efficacy in PTSD Treatment in China
A secondary analysis of a randomized controlled trial indicates that mobile app-delivered Acceptance and Commitment Therapy significantly improves PTSD symptoms through mediating components of psychological flexibility.
Phase III
Psychiatry / PTSD
Status
Positive
Sponsor
digital therapeutics
Signal Score
8.4
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The efficacy of mobile app-delivered Acceptance and Commitment Therapy (ACT) for PTSD treatment underscores the growing importance of digital therapeutics in mental health care. This shift towards digital solutions presents both a challenge and an opportunity for pharma companies to innovate and enhance patient engagement in treatment protocols.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor further studies on digital therapeutics in PTSD and the integration of psychological flexibility components in treatment protocols.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.